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Background: Influenza infection during pregnancy causes significant morbidity and mortality. Immunisation against
influenza is recommended during pregnancy in several countries however, there are limited data on vaccine
uptake, and the determinants of vaccination, in pregnant Australian Aboriginal and/or Torres Islander women. This
study aimed to collect pilot data on vaccine uptake and attitudes towards, and perceptions of, maternal influenza
vaccination in this population in order to inform the development of larger studies.
Methods: A mixed-methods study comprised of a cross-sectional survey and yarning circles (focus groups) amongst
Aboriginal and Torres Strait Islander women attending two primary health care services. The women were between
28 weeks gestation and less than 16 weeks post-birth. These data were supplemented by data collected in an ongoing
national Australian study of maternal influenza vaccination. Aboriginal research officers collected community data and
data from the yarning circles which were based on a narrative enquiry framework. Descriptive statistics were used to
analyse quantitative data and thematic analyses were applied to qualitative data.
Results: Quantitative data were available for 53 women and seven of these women participated in the yarning circles.
The proportion of women who reported receipt of an influenza vaccine during their pregnancy was 9/53. Less than
half of the participants (21/53) reported they had been offered the vaccine in pregnancy. Forty-three percent reported
they would get a vaccine if they became pregnant again. Qualitative data suggested perceived benefits to themselves
and their infants were important factors in the decision to be vaccinated but there was insufficient information available
to women to make that choice.
Conclusions: The rates of influenza immunisation may continue to remain low for Aboriginal and/or Torres Strait
Islander women during pregnancy. Access to services and recommendations by a health care worker may be factors
in the lower rates. Our findings support the need for larger studies directed at monitoring and understanding the
determinants of maternal influenza vaccine uptake during pregnancy in Australian Aboriginal and Torres Strait
Islander women. This research will best be achieved using methods that account for the social and cultural contexts
of Aboriginal and Torres Strait Islander communities in Australia.
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Influenza infection during pregnancy is associated with
increased morbidity, higher rates of hospitalization
than the general population [1,2] and high mortality
rates, particularly during pandemic periods [3]. Conse-
quently, pregnant women are deemed a priority group
for influenza vaccination both in Australia and overseas
[4-6]. Furthermore maternal influenza vaccination
during pregnancy appears to confer protection against
influenza infection in young infants up to six months
of age, a group for whom a licensed influenza vaccine is
not available [7,8].
Aboriginal and/or Torres Strait Islander Australians
are at increased risk of influenza and adverse influenza
infection outcomes [9,10]. Given the increased risk,
annual influenza vaccination is recommended in
Australia, and the vaccine is free, for all Aboriginal
and/or Torres Strait Island Peoples aged 15 years and
older [11]. There are limited data available on uptake
during pregnancy in this population. A large national
study is underway in Australia (the FluMum Study)
[12] however those data will be predominantly derived
from women giving birth in major cities and may not
reflect the experience of women in regional and rural
areas.
In order to achieve high uptake an in-depth under-
standing of the determinants of vaccination is required
through large studies that account for the heterogeneity
of the Australian Aboriginal and Torres Strait Islander
population [13,14]. To inform these studies, we con-
ducted a mixed-methods pilot study of influenza vaccine
uptake, and the factors influencing vaccine uptake,
during pregnancy in Aboriginal and Torres Strait
Islander women attending two Aboriginal and Torres
Strait Islander specific primary health care centres in
south-east Queensland, Australia.Methods
Setting
The study was conducted from January to April 2014 in
Caboolture and Toowoomba, Queensland. Both towns
are within two hours drive of Brisbane, the capital city
of Queensland, and are home to large Aboriginal and
Torres Strait Islander communities. Both towns are
serviced by Aboriginal and Torres Strait Islander specific
primary health care services that include maternal and
child health programs and have total clinic populations
exceeding 3000 clients each.Design
The study utilised a mixed methods approach comprised
of three components:1. An analysis of data collected from women enrolled
in the national FluMum study [12] at the Brisbane
site.
2. A cross-sectional survey of women presenting to the
two primary health care services.
3. Yarning circles (focus groups) [15] of women who
had completed the cross-sectional survey outlined in
step 2.
The study was approved by the Human Research
Ethics Committee of the Queensland University of
Technology (#1300000839).
The FluMum study
FluMum is a national cohort study of influenza vaccine
uptake during pregnancy and the effectiveness of pre-
natal influenza vaccination in preventing laboratory
confirmed influenza in infants. The protocol for this
study has been published elsewhere [12]. For this
current study, we extracted data on women recruited to
the FluMum study for the years 2012 and 2013 who
identified as Aboriginal and/or Torres Strait Islander at
enrolment.
Community-based cross-sectional surveys
We conducted surveys of women presenting to the two
participating health services. Whether or not it was
standard care at these specific health services to rou-
tinely offer and/or provide influenza vaccination to
pregnant women was not considered in the choice of
recruitment sites as women may present to numerous
health care providers (eg midwives, obstetricians,
general practitioners etc.) at several different locations
over the course of their pregnancy. Women were
approached for participation by Aboriginal researchers
who explained the study using a plain language state-
ment and written informed consent was obtained.
Women who agreed to participate in the survey were
asked if they would like to participate in the yarning
groups described below and re-consented to that
component of the research.
Women were eligible for inclusion in the study if they:
identified as Aboriginal and/or Torres Strait Islander;
were aged 17 years or more; were between 28 weeks
gestation and less than 16 weeks post birth; were willing
and able to adhere to all protocol requirements; and,
had sufficient verbal English to permit questionnaire
completion at study entry. There were no specific exclu-
sion criteria.
At the time of recruitment, participants completed a
structured questionnaire with the assistance of the
Aboriginal researcher. This sought self-reported influenza
status, information relating to the barriers/influences of
influenza vaccination, self-reported maternal medical/
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The questionnaire did not specifically relate to whether or
not the participating clinics offered the vaccine or whether
the offer of influenza vaccination during pregnancy was
standard care at those clinics Data were entered into a
password protected, electronic database housed at the
Queensland Children’s Medical Research Institute.
Sample size and statistics
The cross-sectional survey was undertaken as a con-
venience sample. No formal sample size calculations
were undertaken given this was a pilot study. Our
primary outcome and analysis was the proportion of
Aboriginal and/or Torres Strait Islander women who
self-reported that they received an influenza vaccine
during pregnancy. Secondary outcomes included per-
ceptions of influenza and influenza vaccination in
pregnancy. Multivariate logistic regression models were
planned to identify potential independent predictors of
vaccine uptake during pregnancy if sufficient women
were recruited to allow meaningful analysis.
Yarning circles methods
The qualitative arm of the study recognized the social
context of human behaviour and theorized how norms,
routines and patterns of practice develop within those
contexts. It suggested that an individual’s knowledge or
reality is a social product derived from relations with
others through temporal and contextual interactions that
influence and determine meanings and actions [16]. This
approach is directly suited to studying and analyzing
how Aboriginal and Torres Strait Islander women
experience pregnancy and vaccination, as well as con-
textual accounts of decision making around vaccination.
Narrative inquiry guided the process of this study [17,18].
We aimed to enroll a maximum of eight participants per
group (four groups in total). If saturation point had not
been reached following these four groups, a further two
groups were to be conducted.
Data collection and participants
‘Yarning circles’ [15] were held in settings and at a time
convenient to participants. Semi-structured sessions
began with time for the facilitator to build relationships
and rapport with the participants to provide a safe space
to share and consider views in the context of the views
of others [19,20]. Sessions were audiotaped and a
research assistant was present to observe and take notes
during the session. A semi-structured interview guide,
based on the “Theory of Planned Behaviour” [21] was
used to inform the conversations. This theory is an
accepted approach to understanding behavioural choices
of Aboriginal people [22]. The following trigger ques-
tions were employed:1. Can you tell me about what it means to you to be
pregnant, or for your family member to be
pregnant? (exploratory)
– Consider partners, stage of life, other siblings?
2. What has your experience been with influenza?
3. How do you feel about vaccinations? (attitudes)
4. How do you see vaccinations during pregnancy?
(attitudes)
– How do you think others in your community,
such as partners, friends, Aunties, view
vaccination during pregnancy? (subjective norms)
5. Can you think about any things that would influence
you to have or not have vaccinations during
pregnancy? (perceived behavioural control)
6. In relation to being pregnant, can you tell me about
services that you attend or don’t attend? (subjective
norms and perceived behavioural control)
– Why do or don’t you attend these health
services? (perceived behavioural control)
– What does the ideal health service that you might
go to for vaccination look like and what is
important about them?
Data analysis
All yarning circles were transcribed verbatim. The ori-
ginal per protocol analyses of the transcripts included
detailed deductive and inductive processes and plans to
identify and define underlying patterns across the stories
with an emphasis on social, cultural and historical
context. However, given the unanticipated small number
of participants recruited, narrative summaries of the
transcripts and major themes are provided here.
Results
Quantitative data
A total of 741 women were recruited to the FluMum
study in Brisbane in 2012 and 2013. Of these, 16 (2%)
identified as Aboriginal and/or Torres Strait Islander.
Sixty-five women were screened in the community-
based survey and 37 women were enrolled between
January and April 2014. Reasons for non-participation in
the community study included time constraints, the
partner not wanting involvement, ineligibility and
inability to contact after initial screening. This provided
data on a total of 53 women for inclusion in the analysis.
The demographic and pregnancy status of these women
are presented in Table 1.
Knowledge of influenza
All but two women had heard about influenza and 18
(34%) women reported they had received an influenza
vaccine at some time in the past. Twenty-one (40%)
women reported someone had spoken to them about
influenza during their pregnancy and some of these
Table 1 Characteristics of study participants (N = 53),
Influenza immunisation project, Caboolture and
Toowoomba, 2014
Total
Median Age in years (Range) 25 (17 – 39)
English as primary language 53 (100%)
Employment status during pregnancy
Full time 9 (17.0%)
Part time 3 (5.7%)
Casual 5 (9.4%)
Not in paid employment 36 (68.0%)
Education status
Post-school qualifications 13 (24.5%)
Completed secondary school 19 (35.8%)
Did not complete secondary school 18 (34.0%)
Did not respond 4 (7.5%)
Pregnant at enrolment 19 (36%)
Gestational age (weeks) at enrolment 35 (28 – 40)
Gestational age at first antenatal care visit 9 (5 – 32)
Gestational age at birth for infant 38 (35 – 40)
Ever received influenza vaccine 18 (34%)
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women reported they had received that information
from their general practitioner (GP), 14 from a midwife
and seven from other sources (nurse, partner, not speci-
fied, obstetrician). Thirty-nine (39/53) women reported
that they thought getting influenza during their preg-
nancy was a serious disease.
Influenza vaccination during pregnancy
Although nine (9/53) women reported receipt of an
influenza vaccine during their pregnancy, 26/53 said they
knew influenza vaccine was recommended during preg-
nancy. Most women (28/53, 53%) said they would accept
the vaccine if it was offered during their pregnancy,
seven indicated they would not, five did not know and
the data were missing for the remaining seven women.
Whereas nine women said they had received an
influenza vaccine in their pregnancy, 23/53 reported they
were offered the vaccine. Only five of the women who
were offered a vaccine actually received a vaccine during
their pregnancy (an uptake rate of 22% amongst those
that were offered the vaccine). There were 25 women
who reported that they were not offered the vaccine
during their pregnancy and four women who did not
answer the question. Only three of the 25 women who
were not offered the vaccine in their pregnancy said they
would not have accepted the offer. Two women reported
someone had recommended they not get the influenzavaccine during their pregnancy, one by a midwife and
one by a grandmother.
In contrast to the 17% uptake rate for influenza
vaccination during the most recent pregnancy, 25/53
women reported they would get the influenza vaccine if
they became pregnant again, nine said they would not,
six did not know and the data were missing for 13
women.
Perceptions of influenza vaccine in pregnancy
Participants were asked a series of questions about their
perceptions of influenza vaccine in pregnancy and
immunisations in general (Table 2). Few women, regard-
less of their pregnancy vaccination status, thought the
vaccine would stop them from getting influenza in their
pregnancy or that it would stop their newborn from
getting influenza. From a safety perspective, only two of
nine vaccinated women thought a vaccine during preg-
nancy could make them sick compared with 22/42
unvaccinated women. Very few women in either group
thought vaccination in pregnancy could harm the
unborn baby (Table 2).
Yarning circles results
Three yarning circles were held between January and
April 2014. While at least 10 women were consented for
each group, and planned to attend, only seven in total
participated across all three groups. The majority of rea-
sons for non-attendance were related to pregnancy
factors (birth, complications, tiredness) or changes in
personal circumstances. Participants ranged in age from
21 to 34 years and all were mothers of two or more
children. One participant was a practising Aboriginal
Health Worker.
Feelings about pregnancy
One participant expressed she “loved being pregnant”
however others voiced feelings of isolation, heightened
levels of stress, lack of support, concerns about the
impact of their pregnancy on other family members and
that they were struggling emotionally. Regular in-home
support for women experiencing difficulties during their
pregnancies was seen as a particular need that was not
being met.
“I just need basically someone like to sit down to talk
to every now and then and but I did have friends, they
just changed in what they do…..”
Experience with influenza and influenza vaccination
All participants were aware of influenza and had either
been ill themselves or reported illness amongst their
family members. Overall the participants were supportive
of influenza vaccination during pregnancy, and in general,
Table 2 Perceptions of influenza and influenza vaccination*, Influenza immunisation project, Caboolture and
Toowoomba, 2014
Do you think: Vaccinated in pregnancy Unvaccinated in pregnancy
n = 9 (%) n = 42 (%)
Vaccine will stop you getting flu in pregnancy Yes 3 (33%) 15 (36%)
No/Unk 6 (67%) 27 (64%)
Vaccine in pregnancy will lessen severity of flu Yes 4 (44%) 30 (71%)
No/Unk 5 (56%) 12 (29%)
Vaccine in pregnancy could make you sick Yes 2 (22%) 22 (52%)
No/Unk 7 (78%) 20 (48%)
Vaccine in pregnancy is worse than flu in pregnancy Yes 0 (0%) 5 (12%)
No/Unk 9 (100%) 37 (88%)
Vaccine in pregnancy will stop newborn getting flu Yes 2 (22%) 11 (26%)
No/Unk 7 (78%) 31 (74%)
Vaccine in pregnancy could harm unborn baby Yes 1 (11%) 6 (14%)
No/Unk 8 (89%) 36 (86%)
Which of the following statements apply to you?
Think all vaccines are safe 6 (66%) 17 (40%)
Worried about vaccines in pregnancy 3 (33%) 9 (21%)
Allergic to flu vaccine 0 (0%) 0 (0%)
Objects to vaccination in pregnancy 0 (0%) 1 (2%)
Plans to immunise baby 7 (78%) 41 (98%)
Rarely gets sick 3 (33%) 18 (43%)
Doesn’t think flu is serious 1 (11%) 0 (0%)
Can’t afford the cost of flu vaccine 0 (0%) 1 (2%)
*excludes data on 3 women for whom vaccination status was unknown.
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and the unborn child.
F33 “Yeah, I basically find it’s very important to have
it that is like, it’s not mainly for your health, but if
you’re like your kids end up gettin sick too, it’s good for
them to have it too… ….like when you don’t have it
you’re more sicker than when you do have it…like it
calms it down a lot…..”
Participants also thought that influenza vaccination
was important for family members and most thought
that even if it didn’t prevent influenza, the vaccine may
lessen the severity of disease. They were interested in
the safety of the vaccine, what products were used to
make the vaccine and wanted to understand the risks of
vaccination to self and the foetus, this information is
being provided as part of study feedback. All women in-
dicated they would recommend influenza vaccine during
pregnancy to friends and family, and all but one indi-
cated they would be willing to be vaccinated. The par-
ticipant who said she would not be immunized ascribed
this to complications in a past pregnancy. However, shewas supportive of others getting the vaccine, a comment
that was not explored further in the group discussion.
Five of the seven participants were not aware that
influenza vaccination was recommended and available
free for pregnant women. The majority reported their
health service providers had not discussed influenza
vaccination with them during their pregnancies. There
was a need for more health education, awareness and
promotion around influenza vaccinations for pregnant
mothers dedicated specifically to Aboriginal and Torres
Strait Islander peoples and there was not enough infor-
mation in either the community or hospital setting.
Two members discussed doctor-led education sessions,
which would strengthen the relationship between
doctors and patients, with patients obtaining informa-
tion from the source. Other areas discussed included
awareness of the ingredients of the influenza vaccine
and its benefits. One participant indicated that on top
of just providing information, services should just give
the vaccine at the time the person was there as the
steps required to get vaccinated (ie go to pharmacy,
come back to clinic etc.) were difficult to complete
given competing priorities.
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give you all these descriptions and all that but they
don’t do nothing about it… they should just say if you
wanted to get the needle, they should just pull out the
needle …”.
When thinking about what would influence them to
be vaccinated during pregnancy, the majority considered
the potential benefit to themselves and their unborn
child as the primary factor.
Health services
The “ideal” setting for participants with respect to preg-
nancy care and getting vaccinated during pregnancy was
one that was culturally specific, multi-disciplinary, pro-
vided external support services and, importantly, one in
which there was more active involvement of doctors in
discussing vaccination with them. The relationship with
doctors was a recurring theme, with participants often
discussing the limited interaction and communication
they had with their doctors and how they wanted to hear
more from the doctor, not others, about vaccination
during pregnancy.
F32 “…somewhere, where you get treated like a person
and not just a number I suppose, rather than a than
being a cattle prod, so to speak. So get you in get you
out… be done with it…. Someone that’s gonna actually
gonna look at it as a holistic not only just look at you
for being there for a flu vax, ok, your pregnant lets tap
into these services………… ok you’ve got umm diabetes,
let’s do this, let’s do a health assessment, I want the
full coverage for the best for myself, for my family for
my baby…so I want a service that’s actually going to
provide a holistic point of care…….”.
Discussion
This pilot study examined the uptake of influenza vaccine
during pregnancy amongst Aboriginal and Torres Strait
Islander women from two urban/inner regional com-
munities in South East Queensland. We found that less
than half of these women were offered influenza
vaccine whilst they were pregnant and only a small pro-
portion had actually been vaccinated. Forty-seven
percent of this small sample of women indicated they
would get vaccinated if they became pregnant again but
this would still leave half of those women unvaccinated.
Very few women reported that they thought influenza
vaccination in pregnancy would prevent influenza
during their pregnancy nor in their newborns. While
our sample size was small our study confirms a need
for larger studies.
Our findings with respect to low uptake of influenza
vaccination in pregnancy are similar to studies conductedin other populations, albeit with coverage ranging from 10
to 60% [23-27]. Studies that have investigated differences
in uptake within populations have reported lower uptake
in minority groups (eg non-Hispanic African Americans
compared to non-Hispanic Americans in the United
States) and between socio-economic groups [24,28-31].
Potential explanations for these disparities include
access to health services, cost of vaccine and the logis-
tics of being vaccinated and the lack of socio-culturally
appropriate education. The qualitative data arising from
the yarning circles seems to support the latter two
factors as important determinants of vaccine uptake. A
lack of adequate information about the vaccine, why it
is needed and its safety in pregnancy have been identi-
fied as major factors behind pregnant women declining
a vaccine offer [24,31,32]. The majority of both vacci-
nated and unvaccinated women in our study did not
believe the vaccine would prevent influenza in preg-
nancy or that it would prevent influenza in their new-
borns. This suggests the information that is available to
women may not adequately address these issues and
that they may not be discussed in detail with providers
at the time vaccine is recommended or offered.
How women feel about pregnancy may also be a
factor in the conversations about health including
immunisation. As one woman identified: “I just need
basically someone like sit down to talk to every now and
then”…. Further exploration is required about how the
decision about influenza immunisation interplays with
other life issues for women who are pregnant.
The importance of the recommendation for vaccination
by a woman’s practitioner, particularly the medical prac-
titioner, has been documented in several studies
[24,26,31,33]. The level of knowledge a physician has
about influenza vaccination during pregnancy has also
been reported to be associated with vaccine uptake
[34]. Our focus group participants indicated the im-
portance of the medical practitioner in discussing
vaccination during pregnancy. Participants suggested
they preferred to receive the information from their
doctors than others and that doctors needed to be more
involved in discussing vaccination with their patients.
Less than a quarter of the women in our study who were
offered the vaccine (and would have accepted it) were actu-
ally vaccinated. While the survey did not ask why they were
not vaccinated despite an offer of vaccine, our focus groups
suggest that the vaccine not being immediately available at
the time of the offer may play a role. The need to take a
script to a pharmacy, collect the vaccine and return to a
clinic for a second time to be vaccinated was a stated deter-
rent. Provision of vaccine at the time the recommendation
or offer is made is likely to facilitate vaccine uptake,
particularly in outpatient settings where accredited nurse
immunisers are available to administer the vaccine [35].
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volvement of Aboriginal research staff within the two
participating health services and the associated follow-
up. This provided a culturally appropriate approach to
data collection, capacity building for Aboriginal and
Torres Strait Islander staff, students and health service
providers, and identified factors that would need to be
considered in future studies. The combination of both
quantitative and qualitative data provided a richness of
data that could not be achieved by one method alone.
The major limitation of this study is the small
sample size. While larger numbers were planned for
both the community survey and the yarning circles,
this was not achieved within the available time frame.
The predominant barriers to recruitment and to
completion of the yarning circles were either ineligi-
bility or competing priorities for potential participants.
However the study was by design an exploratory pilot
study that has identified key issues needing further
investigation in larger studies.
A further weakness of this study is that we relied on
self-report of vaccination status. There are limited
studies that have evaluated the validity of self-reported
antenatal immunisation amongst pregnant women [36].
The limited data available on the reliability of self-report,
and none for Australian Aboriginal and Torres Strait
Islander women, is a limitation to interpreting coverage
data and monitoring the effectiveness of immunisation
campaigns, particularly when population-based adult
immunisation registers are unavailable. Further studies
need to incorporate validation of self-report into study
procedures.
Conclusion
While the findings of our small study cannot be con-
sidered representative of Australia’s Aboriginal and
Torres Strait Islander population, it suggests influenza
vaccination uptake during pregnancy in Aboriginal
and/or Torres Strait Islander women may be low.
There is a lack of knowledge of the recommendations
for vaccination, health service providers are not uni-
versally offering the vaccine and importantly, women
are not being vaccinated even if the vaccine was
offered. Women reported wanting to hear more from
doctors in regard to influenza immunisation.
While our yarning circles suggest there is a lack of
information available to women, and that the logistics of
being vaccinated even if it is offered or they know it is
recommended, and these are likely to play an important
role in vaccine uptake, our findings point to an urgent
need to repeat the study on a larger scale and in a
broader cross-section of communities. In addition to
exploring in more detail the reasons why women are not
vaccinated even if offered the vaccine, an importantquestion to address is the acceptance of influenza
vaccination during pregnancy in Aboriginal and Torres
Strait Islander women given approximately half of our
study population indicated they would not be vaccinated
in their next pregnancy.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors contributed to the design and implementation of the study. KFO,
MD, LM & JM drafted the manuscript. MD, LM & KH liaised with community,
recruited participants and collected data. KFO analysed the quantitative data.
MD, LM performed the qualitative analyses. All authors reviewed and approved
the final manuscript.
Authors’ information
KFO: BNSc, GDipPH, MAppEpid, PhD, Senior Research Fellow.
(kerryann.ogrady@qut.edu.au)
MD: Cert IV Aboriginal Health Worker, Research Officer
(melissa.dunbar@qut.edu.au)
LM: PhD Candidate (l.medlin@uq.edu.au)
KH: PhD Candidate (k.hall7@uq.edu.au)
MT: BEd(Primary), GCert Tertiary Teaching, PhD, Senior Research Fellow
(m.toombs@uq.edu.au)
JM: BHlthSc, MAppSc (Research), Research Assistant
(Judith.meiklejohn@menzies.edu.au)
LMcH: BNSc, M Applied Epidemiology Scholar (l.mulhearn@uq.edu.au)
PM: DrPH, GCPH, RN, Program Manager Health Protection
(peter.massey@health.nsw.gov.au)
AC: MPhil Candidate (amy.creighton@health.nsw.gov.au)
RA: DipAppSc, MPH, MAppEpid, PhD, Deputy Director
(ross.andrews@menzies.edu.au)
Acknowledgements
The authors would like to acknowledge the traditional custodians of the
lands where the project was conducted, the elders past, present and future.
We would also like to thank the participating communities and health
centres. We would particularly like to thank Jennie Anderson, Anita Kemp,
Shelley Reynolds and Harry Randhawa for supporting and facilitating the
study in their practices. The Queensland Children’s Medical Research
Institute’s Indigenous Research Reference Group oversaw the cultural safety
of the study.
Funding sources
This study was funded via a project grant from the Lowitja Institute. KFO is
supported by a NHMRC Career Development Fellowship (1045157) and a
Queensland Government Smart Futures Fellowship. LM & KH are supported
by an Australian Post-Graduate Award and Supervisor Top Up Scholarship
through the NHMRC Centre for Research Excellence in Lung Health for
Aboriginal and Torres Strait Islander Children. LMcH is supported by a
conjoint scholarship through UQ and QLD Health.
Author details
1Queensland Children’s Medical Research Institute, Queensland University of
Technology, Level 7 Centre for Child Health Research, South Brisbane,
Queensland, Australia. 2University of Queensland Rural Clinical School, School
of Medicine, The University of Queensland, Toowoomba, Queensland,
Australia. 3Menzies School of Health Research, Charles Darwin University,
Spring Hill, Queensland, Australia. 4National Centre for Epidemiology and
Population Health, Australian National University, Canberra, Australian Capital
Territory, Australia. 5Centre for Child Health Research, The University of
Queensland, South Brisbane, Queensland, Australia. 6Communicable Diseases
Branch, Queensland Health, Herston, Queensland, Australia. 7Hunter New
England Population Health, New South Wales Health, Tamworth, New South
Wales, Australia.
Received: 29 July 2014 Accepted: 23 April 2015
O’Grady et al. BMC Research Notes  (2015) 8:169 Page 8 of 8References
1. Hartert TV, Neuzil KM, Shintani AK, Mitchel Jr EF, Snowden MS, Wood LB,
et al. Maternal morbidity and perinatal outcomes among pregnant
women with respiratory hospitalizations during influenza season. Am J
Obstet Gynecol. 2003;189(6):1705–12.
2. Schanzer DL, Langley JM, Tam TW. Influenza-attributed hospitalization rates
among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can.
2007;29(8):622–9.
3. Englund JA. Maternal immunization with inactivated influenza vaccine:
rationale and experience. Vaccine. 2003;21(24):3460–4.
4. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza
in pregnant and postpartum women in California. N Engl J Med.
2010;362(1):27.
5. Mangtani P, Mak TK, Pfeifer D. Pandemic H1N1 infection in pregnant
women in the USA. Lancet. 2009;374(9688):429–30.
6. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical
care services and 2009 H1N1 influenza in Australia and New Zealand.
N Engl J Med. 2009;361(20):1925–34.
7. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Altaye M, et al. M BBSK:
Influenza immunization in pregnancy–antibody responses in mothers and
infants. N Engl J Med. 2010;362(17):1644–6.
8. Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, et al. Maternal
Influenza Vaccination and Effect on Influenza Virus Infection in Young
Infants. Arch Pediatr Adolesc Med. 2010;165(2):104–11.
9. Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases
and vaccination coverage in Aboriginal and Torres Strait Islander people,
Australia 2003 to 2006. Commun Dis Intell. 2008;32 Suppl:S2–67.
10. Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, et al.
Vaccine preventable diseases and vaccination coverage in Aboriginal and
Torres Strait Islander people, Australia 2006–2010. Commun Dis Intell
Q Rep. 2013;37 Suppl:S1–95.
11. National Health & Medical Research Council. The Australian Immunisation
Handbook, 10th Edition. Canberra: Australian Government; 2013.
12. O’Grady KA, McHugh L, Nolan T, Richmond P, Wood N, Marshall HS, et al.
FluMum: a prospective cohort study of mother-infant pairs assessing the
effectiveness of maternal influenza vaccination in prevention of influenza
in early infancy. BMJ Open. 2014;4(6), e005676.
13. O’Grady KA, Krause V, Andrews R. Immunisation coverage in Australian
Indigenous children: Time to move the goal posts. Vaccine.
2009;27(2):307–12.
14. Vlack S, Foster R, Menzies R, Williams G, Shannon C, Riley I. Immunisation
coverage of Queensland indigenous two-year-old children by cluster
sampling and by register. Aust N Z J Public Health. 2007;31(1):67–72.
15. Sheehan N. Indigenous knowledge and respectful design: An evidence-
based approach. Des Issues. 2011;27(4):68–80.
16. Berger P, Luckman R. The Social Construction of Reality: A treatise in
sociology of knowledge. New York: Doubleday; 1966.
17. Josselson R. Narrative research and the challenge of accumulating
knowledge. Narrat Inq. 2006;16(1):3–10.
18. Riessman CK, Speedy J. Narrative inquiry in the psychotherapy professions:
a critical review. In: Clandinin DJ, editor. Handbook of Narrative Inquirty:
Mapping a methodology. Thousand Oaks: Sage Publications;
2007. p. 426–56.
19. Bessarab D, Ng’andu B. Yarning about yarning as a legitimate method in
Indigenous research. Int J Crit Indigenous Stud. 2010;3(1):37–50.
20. Patton MQ. Qualitative Research and Evaluation Methods. 3rd ed.
California: Sage Publications; 2002.
21. Nutbeam DE, Harris E, Wise M. Theory in a Nutshell: a practical guide to
health promotion theories. 3rd ed. Sydney: McGraw Hill; 2010.
22. Campbell D. Is the gap in Aboriginal health the result of rational choice?
In: 32nd Australian Conference for Health Economists. Sydney: Australian
Health Economics Society; 2010.
23. Mak DB, Daly AM, Armstrong PK, Effler PV. Pandemic (H1N1) 2009
influenza vaccination coverage in Western Australia. Med J Aust.
2010;193(7):401–4.
24. Drees M, Johnson O, Wong E, Stewart A, Ferisin S, Silverman PR, et al.
Acceptance of 2009 H1N1 influenza vaccine among pregnant women in
Delaware. Am J Perinatol. 2012;29(4):289–94.
25. Henninger M, Crane B, Naleway A. Trends in influenza vaccine coverage
in pregnant women, 2008 to 2012. Perm J. 2013;17(2):31–6.26. Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, et al. Uptake of
influenza vaccine by pregnant women: a cross-sectional survey. Med J Aust.
2013;198(7):373–5.
27. Maher L, Hope K, Torvaldsen S, Lawrence G, Dawson A, Wiley K, et al.
Influenza vaccination during pregnancy: coverage rates and influencing
factors in two urban districts in Sydney. Vaccine. 2013;31(47):5557–64.
28. Kfouri Rde A, Richtmann R. Influenza vaccine in pregnant women:
immunization coverage and associated factors. Einstein (Sao Paulo).
2013;11(1):53–7.
29. Ross S, Ormandy J, Kim BJ. The uptake rates of influenza vaccine in
pregnant women in the Nelson region of New Zealand. N Z Med J.
2013;126(1372):105–6.
30. White SW, Petersen RW, Quinlivan JA. Pandemic (H1N1) 2009 influenza
vaccine uptake in pregnant women entering the 2010 influenza season in
Western Australia. Med J Aust. 2010;193(7):405–7.
31. Honarvar B, Odoomi N, Mahmoodi M, Kashkoli GS, Khavandegaran F,
Bagheri Lankarani K, et al. Acceptance and rejection of influenza vaccination
by pregnant women in southern Iran: physicians’ role and barriers.
Hum Vaccin Immunother. 2012;8(12):1860–6.
32. Yudin MH, Salaripour M, Sgro MD. Pregnant women’s knowledge of
influenza and the use and safety of the influenza vaccine during
pregnancy. J Obstet Gynaecol Can. 2009;31(2):120–5.
33. Ahluwalia IB, Jamieson DJ, Rasmussen SA, D’Angelo D, Goodman D, Kim H.
Correlates of seasonal influenza vaccine coverage among pregnant women
in Georgia and Rhode Island. Obstet Gynecol. 2010;116(4):949–55.
34. Eppes C, Wu A, Cameron KA, Garcia P, Grobman W. Does obstetrician
knowledge regarding influenza increase HINI vaccine acceptance among
their pregnant patients? Vaccine. 2012;30(39):5782–4.
35. Brown M, Sheppeard V, Gabriel S, Thomas J. Description of the Western
Sydney and Nepean Blue Mountains local health districts’ influenza
prevention programme. Intern Med J. 2013;43(7):760–6.
36. Specker B, Wey B, Fuller J, Sandoval MN, Durkin M, Dole N, et al. 2009 H1N1
and seasonal influenza immunization among pregnant women:
a comparison of different sources of immunization information. Matern
Child Health J. 2014;18(3):681–7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
